Scopolamine API Market, by Form, by Purity, by Scale of Production, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

PUBLISHED: October 10, 2022

PAGES: 202 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Scopolamine is an alkaloid drug extracted from a plant called henbane to treat nausea and motion sickness and further to dilate the pupil in ophthalmic procedures. Scopolamine belongs to a class of drugs called anticholinergic. Scopolamine is a tropane alkaloid isolated from members of the Solanaceae family of plants, similar to atropine and hyoscyamine, all of which structurally mimic the natural neurotransmitter acetylcholine. It works by blocking the activity of the neurotransmitter acetylcholine, which stimulates the part of the brain that triggers nausea and vomiting, involuntary muscle movement in the lungs, and the gastrointestinal and urinary tracts. Scopolamine is also used in medicine as a sedative or hypnotic and sometimes with morphine to relieve pain. Scopolamine has also been prescribed 'off label' for depression, asthma, as a smoking-cessation remedy, and to relieve the nausea that accompanies chemotherapy

Market Dynamics

Scopolamine is effective in reducing depression and anxiety symptoms due to its anxiety-reducing (anxiolytic) effects. Thus the increasing number of people suffering from anxiety is expected to drive the market growth over the forecast period. For instance, according to the Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S. affecting about 40 million adults aged 18 years and older, or 18.1% of the population every year in the U.S.

Moreover, increasing adoption of drug delivery systems such as transdermal patches is expected to drive the market growth over the forecast period. The scopolamine transdermal skin patch is used to prevent nausea and vomiting caused by motion sickness or recovery from anesthesia and surgery.

Key features of the study:

This report provides in-depth analysis of the global scopolamine API market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global scopolamine API market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Phytex Australia., Aspen Holdings, LGM Pharma, Midas Pharma GmbH, Transo-Pharm Handels-GmbH, Aktin Chemicals,Inc, Merck KgaA, Alchem International Pvt. Ltd., Tiefenbacher API + Ingredients GmbH & Co. KG, Spectrum Chemical, Vital Laboratories Pvt Ltd, Clearsynth, Prism Industries Ltd, Alkaloids Corporation., and Manus Aktteva Biopharma LLP
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global scopolamine API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global scopolamine API market

Detailed Segmentation:

Global Scopolamine API Market, By Form:
- Powder
- Liquid
Global Scopolamine API Market, By Purity:
- ≥99%
- ≥ 98%
Global Scopolamine API Market, By Scale of Production:
- Industrial scale
- Pilot scale
- Laboratory scale
Global Scopolamine API Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Region/Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- Phytex Australia.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Aspen Holdings
- LGM Pharma
- Midas Pharma GmbH
- Transo-Pharm Handels-GmbH
- Aktin Chemicals,Inc
- Merck KGaA
- Alchem International Pvt. Ltd.
- Tiefenbacher API + Ingredients GmbH & Co. KG
- Spectrum Chemical
- Vital Laboratories Pvt Ltd
- Clearsynth
- Prism Industries Ltd
- Alkaloids Corporation.
- Manus Aktteva Biopharma LLP

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI5270

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Form
- Market Snapshot, By Purity
- Market Snapshot, By Scale of Production
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
PEST Analysis
Regulatory Scenario
Epidemiology
Acquisition/Agreement Scenario
Key Highlights/Developments
Challenges in Scopolamine API Market

4. Global Scopolamine API Market- Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Demand and Supply Analysis

5. Global Scopolamine API Market, By Form, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Powder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Liquid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Scopolamine API Market, By Purity, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
≥99%
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
≥ 98%
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Scopolamine API Market, By Scale of Production, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Industrial scale
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Pilot scale
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Laboratory scale
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Scopolamine API Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Purity, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Production, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Purity, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Production, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Purity, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Production, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Purity, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Production, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Purity, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Production, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Purity, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Production, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Phytex Australia.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Aspen Holdings
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LGM Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Midas Pharma GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Transo-Pharm Handels-GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Aktin Chemicals,Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Alchem International Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Tiefenbacher API + Ingredients GmbH & Co. KG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Spectrum Chemical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Vital Laboratories Pvt Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Clearsynth
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Prism Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Alkaloids Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Manus Aktteva Biopharma LLP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies